The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
Open accessAbstract
OBJECTIVES: This report reviews the clinical effectiveness and cost-effectiveness of adalimumab, etanercept and infliximab, agents that inhibit tumour necrosis factor-alpha (TNF-alpha), when used in the treatment of rheumatoid arthritis (RA) in adults. DATA SOURCES: Electronic databases were searched up to February 2005. REVIEW METHODS: Systematic reviews of the literature on effectiveness and cost-effectiveness were undertaken and industry submissions to the National Institute for Health and Clinical Excellence (NICE) were reviewed. Meta-analyses of effectiveness data were also undertaken for each agent. The Birmingham Rheumatoid Arthritis Model (BRAM), a simulation model, was further developed and used to produce an incremental cost-effectiveness analysis. RESULTS: Twenty-nine randomised controlled trials (RCTs), most of high quality, were included. The only head-to-head comparisons were against methotrexate. For patients with short disease duration (
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L. M., Lightfoot, R., Paulus, H., Strand, V., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380602 · Cited by 2,829
Maini, R., St Clair, E. W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05246-0 · Cited by 2,345
Weinblatt, M. E., Kremer, J. M., Bankhurst, A. D., Bulpitt, K. J., Fleischmann, R. M., Fox, R. I., Jackson, C. G., Lange, M., & Burge, D. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400401 · Cited by 2,085
Klareskog, L., van der Heijde, D., de Jager, J. P., Gough, A., Kalden, J., Malaise, M., Mola, E. M., Pavelka, K., Sany, J., Settas, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15640-7 · Cited by 1,751
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
Bathon, J. M., Martin, R. W., Fleischmann, R. M., Tesser, J. R., Schiff, M. H., Keystone, E. C., Genovese, M. C., Wasko, M. C., Moreland, L. W., Weaver, A. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432201 · Cited by 1,730
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Chung, E. S., Packer, M., Lo, K. H., Fasanmade, A. A., & Willerson, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000077913.60364.d2 · Cited by 1,644
Maini, R. N., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Davis, D., MACFARLANE, J. D., Antoni, C., Leeb, B. F., Elliott, M. J., Woody, J. N., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9<1552::aid-art5>3.0.co;2-w · Cited by 1,623
van Gestel, A. M., Prevoo, M. L. L., van't Hof, M. A., van Rijswijk, M. H., van de Putte, L. B. A., & van Riel, P. L. C. M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390105 · Cited by 1,572
The mortality of rheumatoid arthritis
Wolfe, F., Mitchell, D. M., Sibley, J. T., Fries, J. F., Bloch, D. A., Williams, C. A., Spitz, P. W., Haga, M., Kleinheksel, S. M., & Cathey, M. A. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370408 · Cited by 1,310
Keystone, E. C., Kavanaugh, A. F., Sharp, J. T., Tannenbaum, H., Hua, Y., Teoh, L. S., Fischkoff, S. A., & Chartash, E. K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20217 · Cited by 1,172
INFLIXIMAB AND METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS
Ipsky, P. E. E. L., Illiam, E. W., Urst, D. A. E. F., Reedveld, C. B., Oachim, J., Alden, R. K., Osef, J., Molen, S. S., Eisman, M. I. W., Mery, P. A. E., et al. (2000) · Cited by 1,155
St. Clair, E. W., van der Heijde, D. M. F. M., Smolen, J. S., Maini, R. N., Bathon, J. M., Emery, P., Keystone, E., Schiff, M., Kalden, J. R., Wang, B., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20568 · Cited by 1,143
Boers, M., Verhoeven, A. C., Markusse, H. M., van de Laar, M. A., Westhovens, R., van Denderen, J. C., van Zeben, D., Dijkmans, B. A., Peeters, A. J., Jacobs, P., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01300-7 · Cited by 1,073
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2196::aid-art15>3.0.co;2-2 · Cited by 981
Möttönen, T., Hannonen, P., Leirisalo-Repo, M., Nissilä, M., Kautiainen, H., Korpela, M., Laasonen, L., Julkunen, H., Luukkainen, R., Vuori, K., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08513-4 · Cited by 865
Evers, S., Goossens, M., de Vet, H., van Tulder, M., & Ament, A. (2005) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462305050324 · Cited by 856
Hurst, N. P., Kind, P., Ruta, D., Hunter, M., & Stubbings, A. (1997) · Rheumatology · doi:10.1093/rheumatology/36.5.551 · Cited by 826
Validation of rheumatoid arthritis improvement criteria that include simplified joint counts
van Gestel, A. M., Haagsma, C. J., & van Riel, P. L. C. M. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199810)41:10<1845::aid-art17>3.0.co;2-k · Cited by 803
Smolen, J. S., Kalden, J. R., Scott, D. L., Rozman, B., Kvien, T. K., Larsen, A., Loew-Friedrich, I., Oed, C., & Rosenburg, R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09403-3 · Cited by 771
Gardam, M. A., Keystone, E. C., Menzies, R., Manners, S., Skamene, E., Long, R., & Vinh, D. C. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00545-0 · Cited by 752
How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis
Visser, H., le Cessie, S., Vos, K., Breedveld, F. C., & Hazes, J. M. W. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10117 · Cited by 731
The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century
Symmons, D. (2002) · Rheumatology · doi:10.1093/rheumatology/41.7.793 · Cited by 646
van de Putte, L. B. A., Atkins, C., Malaise, M., Sany, J., Russell, A. S., van Riel, P. L. C. M., Settas, L., Bijlsma, J. W., Todesco, S., Dougados, M., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.013052 · Cited by 617
Genovese, M. C., Cohen, S., Moreland, L., Lium, D., Robbins, S., Newmark, R., Bekker, P., & for the 20000223 Study Group (2004) · Arthritis & Rheumatism · doi:10.1002/art.20221 · Cited by 532
Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis
Tugwell, P., Pincus, T., Yocum, D., Stein, M., Gluck, O., Kraag, G., McKendry, R., Tesser, J., Baker, P., & Wells, G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507203330301 · Cited by 530
Quinn, M. A., Conaghan, P. G., O'Connor, P. J., Karim, Z., Greenstein, A., Brown, A., Brown, C., Fraser, A., Jarret, S., & Emery, P. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20712 · Cited by 529
Survival in rheumatoid arthritis: A population‐based analysis of trends over 40 years
Gabriel, S. E., Crowson, C. S., Kremers, H. M., Doran, M. F., Turesson, C., O'Fallon, W. M., & Matteson, E. L. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10705 · Cited by 516
Maini, R. N., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Furst, D., Weisman, M. H., St.Clair, E. W., Keenan, G. F., van der Heijde, D., Marsters, P. A., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20159 · Cited by 514
Furst, D. E., Schiff, M. H., Fleischmann, R., Strand, V., Birbara, C. A., Compagnone, D., Fischkoff, S. A., & Chartash, E. (2003) · PubMed · Cited by 495
Emery, P., Breedveld, F. C., Lemmel, E. M., Kaltwasser, J. P., Dawes, P. T., Gömör, B., Van den Bosch, F., Nordström, D., Bjørneboe, O., Dahl, R., et al. (2000) · Rheumatology · doi:10.1093/rheumatology/39.6.655 · Cited by 472
Health Technology Assessment (HTA)
Greiner, W. (2008) · Gesundheitsökonomische Evaluationen · doi:10.1007/978-3-540-49559-8_19 · Cited by 462
Heijde, D. M. F. M. V. D., Leeuwen, M. A. V., Riel, P. L. C. M. V., Koster, A. M., Hof, M. A. V., Rijswijk, M. H. V., & Putte, L. B. A. V. D. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350105 · Cited by 447
Geborek, P., Bladström, A., Turesson, C., Gulfe, A., Petersson, I. F., Saxne, T., Olsson, H., & Jacobsson, L. T. H. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.030528 · Cited by 427
Sharp, J. T., Young, D. Y., Bluhm, G. B., Brook, A., Brower, A. C., Corbett, M., Decker, J. L., Genant, H. K., Gofton, J. P., Goodman, N., et al. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780281203 · Cited by 417
Askling, J., Fored, C. M., Baecklund, E., Brandt, L., Backlin, C., Ekbom, A., Sundström, C., Bertilsson, L., Cöster, L., Geborek, P., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.033241 · Cited by 417
Baecklund, E., Ekbom, A., Sparén, P., Feltelius, N., & Klareskog, L. (1998) · BMJ · doi:10.1136/bmj.317.7152.180 · Cited by 394
Askling, J., Fored, C. M., Brandt, L., Baecklund, E., Bertilsson, L., Feltelius, N., Cöster, L., Geborek, P., Jacobsson, L. T., Lindblad, S., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.033993 · Cited by 377
[Etanercept for therapy of rheumatoid arthritis].
Miyasaka, N. (2005) · PubMed · Cited by 367
Matuszewski, K. A. (2005) · Epidemiology and the Delivery of Health Care Services · doi:10.1007/0-306-47557-x_10 · Cited by 337
Weisman, M. H., Moreland, L. W., Furst, D. E., Weinblatt, M. E., Keystone, E. C., Paulus, H. E., Teoh, L. S., Velagapudi, R. B., Noertersheuser, P. A., Granneman, G. R., et al. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80164-9 · Cited by 303
Pincus, T., Marcum, S., & Callahan, L. F. (1992) · PubMed · Cited by 287
Jacoby, R. K., Jayson, M. I. V., & Cosh, J. A. (1973) · BMJ · doi:10.1136/bmj.2.5858.96 · Cited by 286
Keystone, E. C., Schiff, M. H., Kremer, J. M., Kafka, S., Lovy, M., DeVries, T., & Burge, D. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20019 · Cited by 284
Michaud, K., Messer, J., Choi, H. K., & Wolfe, F. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11439 · Cited by 271
Young, A., Dixey, J., Kulinskaya, E., Cox, N., Davies, P., Devlin, J., Emery, P., Gough, A., James, D., Prouse, P., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.4.335 · Cited by 260
A review of the MHC genetics of rheumatoid arthritis
Newton, J., Harney, S., Wordsworth, B., & Brown, M. (2004) · Genes & Immunity · doi:10.1038/sj.gene.6364045 · Cited by 258
Barrett, E. M. (2000) · Rheumatology · doi:10.1093/rheumatology/39.12.1403 · Cited by 258
Felson, D. T., Anderson, J. J., & Meenan, R. F. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780351003 · Cited by 230
Smeets, T. J. M., Kraan, M. C., van Loon, M. E., & Tak, P. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11098 · Cited by 224
Moreland, L. W., Margolies, G., Heck, L. W., Saway, A., Blosch, C. D., Hanna, R. K., & Koopman, W. J. (1996) · PubMed · Cited by 215
Kollias, G., Douni, E., Kassiotis, G., & Kontoyiannis, D. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.2008.i32 · Cited by 210
Hickling, P., Jacoby, R. K., & Kirwan, J. R. (1998) · Rheumatology · doi:10.1093/rheumatology/37.9.930 · Cited by 201
Xanthoulea, S., Pasparakis, M., Kousteni, S., Brakebusch, C., Wallach, D., Bauer, J., Lassmann, H., & Kollias, G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040435 · Cited by 196
den Broeder, A. A., van de Putte, L., Rau, R., Schattenkirchner, M., van Riel, P. L. C. M., Sander, O., Binder, C., Fenner, H., Bankmann, Y., Velagapudi, R. B., et al. (2002) · PubMed · Cited by 195
Kavanaugh, A., Clair, E. W. S., Wj, M., Braakman, T., & Lipsky, P. E. (2000) · PubMed · Cited by 194
Maetzel, A., Wong, A., Strand, V., Tugwell, P., Wells, G., & Bombardier, C. (2000) · Rheumatology · doi:10.1093/rheumatology/39.9.975 · Cited by 184
Puolakka, K., Kautiainen, H., Möttönen, T., Hannonen, P., Korpela, M., Julkunen, H., Luukkainen, R., Vuori, K., Paimela, L., Blåfield, H., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11436 · Cited by 177
van de Putte, L. B. A., Rau, R., Breedveld, F. C., Kalden, J. R., Malaise, M. G., van Riel, P. L. C. M., Schattenkirchner, M., Emery, P., Burmester, G. R., Zeidler, H., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.009563 · Cited by 176
Brouwer, W. B. F., van Exel, N. J. A., van de Berg, B., Dinant, H. J., Koopmanschap, M. A., & van den Bos, G. A. M. (2004) · Arthritis Care & Research · doi:10.1002/art.20528 · Cited by 168
Kobelt, G., Jönsson, L., Young, A., & Eberhardt, K. (2003) · Rheumatology · doi:10.1093/rheumatology/keg107 · Cited by 160
Scott, D. L., Shipley, M. E., Dawson, A., Edwards, S. M., Symmons, D. P. M., & Woolf, A. D. (1998) · Rheumatology · doi:10.1093/rheumatology/37.5.546 · Cited by 152
Clinical Trials Update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH
Coletta, A. P., Clark, A. L., Banarjee, P., & Cleland, J. G. F. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00121-6 · Cited by 140
Kobelt, G., Eberhardt, K., & Geborek, P. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.010629 · Cited by 137
Jones, G. (2002) · British journal of rheumatology · doi:10.1093/rheumatology/keg036 · Cited by 131
Serum methylprednisolone levels following intra-articular injection of methylprednisolone acetate.
Armstrong, R. D., English, J., Gibson, T., Chakraborty, J., & Marks, V. (1981) · Annals of the Rheumatic Diseases · doi:10.1136/ard.40.6.571 · Cited by 129
Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis
Wong, J. B., Singh, G., & Kavanaugh, A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01243-3 · Cited by 129
Jobanputra, P., Barton, P., Bryan, S., & Burls, A. (2002) · Health Technology Assessment · doi:10.3310/hta6210 · Cited by 126
Self-citationBarton, P. M., Jobanputra, P., Wilson, J. L., Bryan, S., & Burls, A. (2004) · Health Technology Assessment · doi:10.3310/hta8110 · Cited by 125
Self-citationBansback, N. J., Brennan, A., & Ghatnekar, O. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.027565 · Cited by 121
Willkens, R. F., Urowitz, M. B., Stablein, D. M., McKendry, R. J. R., Berger, R. G., Box, J., Fiechtner, J. J., Fudman, E. J., Hudson, N. P., Marks, C. R., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350802 · Cited by 118
Patient preferences for treatment of rheumatoid arthritis
Fraenkel, L., Bogardus, S. T., Concato, J., Felson, D. T., & Wittink, D. R. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.019422 · Cited by 113
Gerards, A., Landewé, R., Prins, A. P. A., Bruijn, G., Thé, H. S. G., Laan, R., & Dijkmans, B. A. C. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.4.291 · Cited by 101
Khanna, D., McMahon, M. A., & Furst, D. E. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20164 · Cited by 98
Clark, W. K., Jobanputra, P., Barton, P. M., & Burls, A. (2004) · Health Technology Assessment · doi:10.3310/hta8180 · Cited by 96
Self-citationUhlig, T., Smedstad, L. M., Vaglum, P., Moum, T., Gérard, N., & Kvien, T. K. (2000) · Lara D. Veeken · doi:10.1093/rheumatology/39.7.732 · Cited by 95
Combination therapy in rheumatoid arthritis: updated systematic review
Verhoeven, A. C., Boers, M., & Tugwell, P. (1998) · Rheumatology · doi:10.1093/rheumatology/37.6.612 · Cited by 94
Fleischmann, R., Baumgartner, S. W., Tindall, E. A., Weaver, A. L., Moreland, L. W., Schiff, M. H., Martin, R. W., & Spencer-Green, G. (2003) · PubMed · Cited by 86
Prospects for B-cell-targeted therapy in autoimmune disease
Edwards, J., & Cambridge, G. (2004) · Rheumatology · doi:10.1093/rheumatology/keh446 · Cited by 84
PROPOSED MODIFICATION TO LARSEN'S SCORING METHODS FOR HAND AND WRIST RADIOGRAPHS
Scott, D. L., Houssien, D. A., & Laasonen, L. (1995) · Lara D. Veeken · doi:10.1093/rheumatology/34.1.56 · Cited by 82
Ward, M. M. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1467::aid-art243>3.0.co;2-6 · Cited by 81
Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity
Navarro-Cano, G., del Rincón, I., Pogosian, S. A., Roldán, J. F., & Escalante, A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11127 · Cited by 75
A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis
Jobanputra, P. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keh003 · Cited by 75
Self-citationChoy, E., Kingsley, G. H., Khoshaba, B., Pipitone, N., & Scott, D. L. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.030908 · Cited by 74
Why does tumor necrosis factor targeted therapy reactivate tuberculosis?
Ehlers, S. (2005) · PubMed · Cited by 73
Edwards, C. J., Arden, N., Fisher, D., Saperia, J., Reading, I., van Staa, T. P., & Cooper, C. C. (2005) · Lara D. Veeken · doi:10.1093/rheumatology/kei024 · Cited by 70
Management of early rheumatoid arthritis
Dubey, S., & Gaffney, K. (2005) · Clinical Medicine · doi:10.7861/clinmedicine.5-3-211 · Cited by 69
Labour force participation among patients with rheumatoid arthritis
Chorus, A. M. J., Miedema, H. S., Wevers, C. J., & van der Linden, S. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.7.549 · Cited by 64
Symmons, D. P. M., & Silman, A. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20312 · Cited by 60
Sokka, T., Möttönen, T. T., & Hannonen, P. (2000) · Lara D. Veeken · doi:10.1093/rheumatology/39.1.34 · Cited by 60
Patient preferences in choosing anti-TNF therapies-R1
Williams, E. L., & Edwards, C. J. (2006) · Lara D. Veeken · doi:10.1093/rheumatology/kel369 · Cited by 58
Welsing, P. M. J., Severens, J. L., Hartman, M., van Riel, P. L. C. M., & Laan, R. (2004) · Arthritis Care & Research · doi:10.1002/art.20843 · Cited by 55
Lan, J. L., Chou, S. J., Chen, D. Y., Chen, Y.-H., Hsieh, T., & Young, M. M. (2004) · PubMed · Cited by 53
Self-citationWiles, N., Scott, D. G. I., Barrett, E. M., Merry, P., Arié, E., Gaffney, K., Silman, A. J., & Symmons, D. P. M. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.10.956 · Cited by 53
Leflunomide in active rheumatoid arthritis: a prospective study in daily practice
van Roon, E. N., Jansen, T., Mourad, L., Houtman, P. M., Bruyn, G. A. W., Griep, E. N., Wilffert, B., Tobi, H., & Brouwers, J. R. B. J. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02131.x · Cited by 47
Durez, P., Toukap, A. N., Lauwerys, B. R., Manicourt, D. H., Verschueren, P., Westhovens, R., Devogelaer, J.-P., & Houssiau, F. A. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.012914 · Cited by 45
Boers, M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21106 · Cited by 42
Do rheumatology cost-effectiveness analyses make sense?
Wolfe, F. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keh034 · Cited by 35
Hamilton, J., McInnes, I. B., Thomson, E. A., Porter, D., Hunter, J. A., Madhok, R., & Capell, H. A. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.6.566 · Cited by 34
Kvien, T. K., Zeidler, H., Hannonen, P., Wollheim, F. A., Førre, Ø. T., Hafström, I., Kaltwasser, J. P., Leirisalo‐Repo, M., Manger, B., Laasonen, L., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.511 · Cited by 32
Compliance with drug therapy in rheumatoid arthritis. A longitudinal European study.
Viller, F., Guillemin, F., Briançon, S., Moum, T., Suurmeijer, T. P. B. M., & van den Heuvel, W. J. (2000) · PubMed · Cited by 28
Edwards, C. J., Arden, N., van Staa, T. P., Reading, I., Saperia, J., Fisher, D. J., & Cooper, C. C. (2005) · Lara D. Veeken · Cited by 21
AN AUDIT OF METHOTREXATE AND FOLIC ACID FOR RHEUMATOID ARTHRITIS. EXPERIENCE FROM A TEACHING CENTRE
Jobanputra, P., Hunter, M. T., CLARK, D., Lambert, C., & Hurst, N. P. (1995) · Lara D. Veeken · doi:10.1093/rheumatology/34.10.971 · Cited by 17
Self-citationShigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Scott, D. L., Wolfe, F., & Huizinga, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60826-4 · Cited by 3,013
Emery, P., Keystone, E., Tony, H. P., Cantagrel, A., van Vollenhoven, R., Sanchez, A., Alecock, E., Lee, J., & Kremer, J. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092932 · Cited by 1,104
van Assen, S., Agmon-Levin, N., Elkayam, O., Cervera, R., Doran, M. F., Dougados, M., Emery, P., Geborek, P., Ioannidis, J. P. A., Jayne, D. R. W., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137216 · Cited by 630
Solovic, I., Sester, M., Gomez-Reino, J. J., Rieder, H. L., Ehlers, S., Milburn, H. J., Kampmann, B., Hellmich, B., Groves, R., Schreiber, S., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00028510 · Cited by 527
Nam, J. L., Winthrop, K. L., van Vollenhoven, R. F., Pavelka, K., Valesini, G., Hensor, E. M. A., Worthy, G., Landewé, R., Smolen, J. S., Emery, P., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.126573 · Cited by 406
Metadata
- Authors
- Chen, Y.-F., Jobanputra, P., Barton, P., Jowett, S., Bryan, S., Clark, W., Fry-Smith, A., & Burls, A.
- Venue
- Health Technology Assessment
- Published
- 2006-11
- Volume
- 10
- Issue
- 42
- Pages
- iii-iv, xi
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2162254515
- Cited by
- 406
- References
- 107
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.